TITANBIO.BO BSE
Titan Biotech Limited
1W: -1.4%
1M: -0.9%
3M: +0.6%
YTD: +89.6%
1Y: -11.0%
3Y: +18.6%
5Y: +17.1%
₹383.10 ($3.98)
-8.40 (-2.15%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$2.1B
+22.4% ▲
5Y CAGR: +16.3%
Total Liabilities
$323M
+51.8% ▲
5Y CAGR: +2.7%
Shareholders Equity
$1.8B
+18.3% ▲
5Y CAGR: +21.4%
Cash & Investments
$19M
-66.3% ▼
5Y CAGR: -19.2%
Total Debt
$57M
+104.1% ▲
5Y CAGR: -17.3%
Net Debt
$38M
+264.5% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $68M | $49M | $28M | $51M | $19M |
| Short-Term Investments | $0 | $0 | $0 | $4M | $0 |
| Cash & ST Investments | $68M | $49M | $28M | $56M | $19M |
| Net Receivables | $164M | $47M | $187M | $188M | $228M |
| Inventory | $347M | $362M | $466M | $507M | $558M |
| Other Current Assets | -$31M | $210M | $38M | $39M | $48M |
| Total Current Assets | $638M | $683M | $722M | $790M | $852M |
| Property, Plant & Equip. | $385M | $491M | $545M | $588M | $633M |
| Goodwill & Intangibles | $1M | $852K | $950K | $1M | $839K |
| Long-Term Investments | $42M | $157M | $285M | $348M | $652M |
| Other Non-Current Assets | $15M | $5M | $13M | $19M | $1M |
| Total Non-Current Assets | $443M | $662M | $844M | $957M | $1.3B |
| Total Assets | $1.1B | $1.3B | $1.6B | $1.7B | $2.1B |
| — Liabilities — | |||||
| Accounts Payable | $42M | $55M | $34M | $52M | $85M |
| Short-Term Debt | $65M | $67M | $67M | $19M | $33M |
| Deferred Revenue | $13M | $21M | $20M | $0 | $0 |
| Other Current Liabilities | $8M | $53M | $61M | $101M | $122M |
| Total Current Liabilities | $169M | $204M | $191M | $177M | $260M |
| Long-Term Debt | $11M | $3M | $5M | $2M | $3M |
| Other Non-Current Liab. | $14M | $16M | $15M | $16M | $23M |
| Total Non-Current Liabilities | $49M | $43M | $40M | $36M | $64M |
| Total Liabilities | $218M | $246M | $236M | $213M | $323M |
| — Equity — | |||||
| Common Stock | $83M | $83M | $83M | $83M | $83M |
| Retained Earnings | $760M | $928M | $1.2B | $1.4B | $0 |
| Accumulated OCI | $886K | $2M | $3M | $4M | $0 |
| Total Stockholders Equity | $862M | $1.1B | $1.3B | $1.5B | $1.8B |
| Total Liabilities & Equity | $1.1B | $1.3B | $1.6B | $1.7B | $2.1B |
| — Key Metrics — | |||||
| Total Debt | $89M | $85M | $83M | $28M | $57M |
| Net Debt | $21M | $36M | $55M | -$23M | $38M |
| Total Investments | $42M | $157M | $285M | $352M | $652M |